Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

@article{Taylor2018KetamineFS,
  title={Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial},
  author={J H Taylor and Angeli Landeros-Weisenberger and Catherine G Coughlin and Jilian M Mulqueen and Jessica A Johnson and Daniel Gabriel and Margot O Reed and Ewgeni Jakubovski and Michael H Bloch},
  journal={Neuropsychopharmacology},
  year={2018},
  volume={43},
  pages={325-333}
}
Many patients with social anxiety disorder (SAD) experience inadequate symptom relief from available treatments. Ketamine is a potent N-methyl-D-aspartate receptor antagonist with a potentially novel mechanism of action for the treatment of anxiety disorders. Therefore, we conducted a double-blind, randomized, placebo-controlled crossover trial in 18 adults… CONTINUE READING